Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-9.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -23.10% |
| 2024 | -19.66% |
| 2023 | -16.06% |
| 2022 | 44.24% |
| 2021 | 38.89% |
| 2020 | 2.51% |
| 2019 | 30.99% |
| 2018 | 123.51% |
| 2017 | 0.10% |
| 2016 | 63.22% |